Cross-sectional increase of adherence to multidisciplinary tumor board decisions

by S. Hollunder, U. Herrlinger, M. Zipfel, J. Schmolders, V. Janzen, T. Thiesler, E. Güresir, A. Schröck, F. Far, T. Pietsch, D. Pantelis, D. Thomas, S. Vornholt, N. Ernstmann, T. Manser, M. Neumann, B. Funke, I. G. H. Schmidt-Wolf
Published 2018-09-01

Contrasting genomic profiles in post-systemic treatment metastatic sites (MET) and pre-treatment primary tumors (PT) of clinically advanced prostate cancer (PC)

by A. Necchi, P. Grivas, G. Bratslavsky, O. Shapiro, J. Jacob, E. Sokol, J. Vergilio, J. Killian, D. Lin, J. Haberberger, J. Tse, S. Ramkissoon, E. Severson, A. Hemmerich, R. Huang, S. Ali, J. Chung, R. Madison, B. Alexander, P. Reddy, J. Elvin, A. Schrock, N. Danziger, J. Ross
Published 2020-07-01